Eyelash Anatomy & Growth Cycle — A Physician's Guide
Part of: Lash & Brow Anatomy Hub
By Dr. Susan Lin, M.D. — Inventor on US Patent 8,206,695. Reviewed June 2026.
The short answer
Eyelashes have fundamentally different anatomy from scalp hair. The average adult has 200-300 lashes per eye, with a growth cycle that takes 4-11 months total — anagen (growth) only 30-45 days, telogen (rest) about 100 days. Only 35-40% of lashes are in growth phase at any moment, compared to 85-90% for scalp hair. This is why visible lash improvement from any conditioning product takes 12-16 weeks of consistent daily use to fully assess. Because lash follicles sit directly adjacent to the ocular surface, ocular safety is the defining feature of a responsibly formulated lash product — a principle I built into MD Lash Factor® when I developed and patented the formulation.
Eyelash counts and distribution
- Upper lid: 90-160 lashes per eye, in 5-6 rows
- Lower lid: 75-80 lashes per eye, in 3-4 rows
- Total per eye: ~200-300 lashes when healthy
- Hair shaft length (healthy): 8-12 mm upper, 6-8 mm lower
The eyelash growth cycle
| Phase | Duration | % of lashes at any moment |
|---|---|---|
| Anagen (growth) | 30-45 days | 35-40% |
| Catagen (regression) | ~15 days | ~10% |
| Telogen (rest then shed) | ~100 days | ~50% |
Implication: at any moment, half your lashes are in the resting phase preparing to shed. Daily loss of 1-5 lashes is normal. Loss of 5-10 per day suggests an active trigger; persistent loss above 10 per day warrants evaluation.
Lash follicle anatomy
Lash follicles are specialized:
- Angled growth — follicles tilt to grow upward and outward (upper) or downward (lower)
- Larger sebaceous glands proportionally — produces lipid coating that conditions the lash shaft
- Adjacent to the ocular surface — just millimeters from the cornea, conjunctiva, and lacrimal duct
- Innervated for blink reflex — lashes serve a sensory protective function
The proximity to the eye is what makes ocular safety the defining feature of any product designed to support lash health.
Common causes of eyelash thinning
- Mechanical trauma — lash curlers used incorrectly (clamping near the lash line), harsh makeup removal, eye rubbing, lash extension lift-offs
- Allergic reactions — mascara, eye makeup, lash extension adhesives, eye drops
- Hypothyroidism — affects all body hair including lashes
- Aging — gradual reduction in follicle activity
- Autoimmune — alopecia areata, trichotillomania (pulling)
- Nutritional deficiencies — especially iron, biotin, protein
- Telogen effluvium — postpartum, severe illness, stress can affect lashes too
The MD Lash Factor® approach — ocular safety as the foundation
Because lash follicles sit just millimeters from the cornea, conjunctiva, and lacrimal duct, ocular safety is the defining feature of any responsibly formulated lash product.
MD Lash Factor® is built around this principle. The original formulation uses dechloro ethylcloprostenolamide, a cosmetic-concentration compound in the prostaglandin family, developed by Dr. Susan Lin, M.D. and protected by Dr. Lin’s eyelash-enhancement patent portfolio (U.S. Patent 8,206,695; Chinese Patent CN 102172344; international WIPO filing). The active is fully disclosed on every package. It does not contain bimatoprost, latanoprost, or any prescription-grade prostaglandin drug. To our knowledge, the original MD Lash Factor remains the only cosmetic prostaglandin-containing eyelash conditioner backed by a published peer-reviewed clinical safety and efficacy study (Choy I, Lin SF, 2008; PMID 18569264). The randomized, double-blind, placebo-controlled trial demonstrated:
- Lengthening and densification of lashes (statistically significant over 4 weeks)
- No clinically meaningful change in visual acuity
- No clinically meaningful change in intraocular pressure
- Tolerance in contact lens wearers and self-assessed sensitive-eye participants
For consumers who prefer a non-prostaglandin approach, MD Lash Factor also offers a peptide-based formulation with no prostaglandin-family compounds, built around a peptide and botanical conditioning blend. Both MD Lash Factor formulations have been evaluated through an independent IRB-protocoled ocular safety framework — a 4-week ophthalmologist-led study at Clinical Research Laboratories (enrolling contact lens wearers and self-assessed sensitive-eye participants), Repeat Insult Patch Testing on 200+ subjects, the Local Lymph Node Assay (LLNA) for sensitization, the Ames mutagenicity assay, and a formal EU Safety Assessment under Regulation EC 1223/2009. Both formulations have been found safe and efficacious. Supporting actives in both formulations include biotin, panthenol, thiotaine, and a peptide complex for conditioning and shaft support.
How to apply MD Lash Factor®
- Cleanse the eye area thoroughly to remove all makeup and oils
- Apply one stroke per eye along the upper lash line using the supplied fine-tip applicator
- Avoid getting product directly in the eye
- Allow to absorb before applying any other eye products
- Use once nightly consistently for 12-16 weeks for full results
Frequently asked questions
Q: How many lashes do I have?
A: 200-300 per eye when healthy (upper + lower combined).
Q: How long is the lash growth cycle?
A: 4-11 months total. Only 35-40% of lashes in growth at any moment.
Q: How long until eyelashes grow back?
A: After loss: 6-8 weeks for initial regrowth, 12-16 weeks for full restoration.
Q: What causes lash thinning?
A: Mechanical trauma, allergic reactions, hypothyroidism, aging, autoimmune conditions, nutritional deficiencies.
Related reading
- How to Choose a Safe Lash Serum — A Physician’s Guide
- Brow Thinning — Causes & Physician’s Guide
- MD Lash Factor Clinical Evidence Dossier
- Lash & Brow Anatomy Hub
Featured product
- MD Lash Factor® — Physician-formulated by Dr. Susan Lin, M.D., U.S. Patent 8,206,695, peer-reviewed published clinical study (JCLT 2008, PMID 18569264), independent IRB-protocoled ocular safety portfolio
Cited literature
- Choy I, Lin SF. A new eyelash care system stimulates eyelash growth: a randomized, double-blind, placebo-controlled study. J Cosmet Laser Ther. 2008;10(2):117–122. PMID: 18569264. DOI: 10.1080/14764170802054138.
Educational only; not a substitute for individualized medical advice.
